• KANAD
  • Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Articles

Original Article

Cost-effectiveness Analysis of Home Care Services for Patients with Diabetic Foot

Journal of Korean Academy of Nursing Administration 2013;19(4):437-448.
Published online: September 30, 2013

1Department of Nursing, Ajou University Hospital, Korea.

2College of Nursing, Ajou University, Korea.

3College of Nursing, Seoul National University, Korea.

Corresponding author: Kim, Yong Soon. College of Nursing, Ajou University, San 5, Wonchun-dong, Yeongtong-gu, Suwon 443-721, Korea. Tel: +82-31-219-7010, Fax: +82-31-219-7020, ysk48@ajou.ac.kr
• Received: March 11, 2013   • Revised: May 20, 2013   • Accepted: June 9, 2013

Copyright © 2013 Korean Academy of Nursing Administration

  • 17 Views
  • 0 Download
next
  • Purpose
    This study was a retrospective survey to examine economic feasibility of home care services for patients with diabetic foot.
  • Methods
    The participants were 33 patients in the home care services (HC) group and 27 in the non-home care services (non-HC) group, all of whom were discharged early after inpatient treatment. Data were collected from medical records. Direct medical costs were calculated using medical fee payment data. Cost-effectiveness ratio was calculated using direct medical costs paid by the patient and the insurer until complete cure of the diabetic foot. Effectiveness was the time required for a complete cure. Direct medical costs included fees for hospitalization, emergency care, home care, ambulatory fees, and hospitalization or ambulatory fees at other medical institutions.
  • Results
    Mean for direct medical costs was 11,118,773 won per person in the HC group, and 16,005,883 won in the non-HC group. The difference between the groups was statistically significant (p=.042). Analysis of the results for cost-effectiveness ratio showed 91,891 won per day in the HC patients, and 109,629 won per day in the non-HC patients.
  • Conclusion
    Result shows that the cost-effectiveness ratio is lower HC patients than non-HC patients, that indicates home care services are economically feasible.

This article is a condensed form of the first author's doctoral dissertation from Ajou University.

  • 1. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev. 2000;16:S75-S83.
  • 2. Basic statistics diabetes Task Force Team. Basic statistics on diabetes Task Force Team report: Diabetes in Korea 2007. Seoul: Korean Diabetes Association & Health Insurance Review & Assessment Service; 2007.
  • 3. In: Bryant RA, Nix DP. editors. Acute & chronic wounds current management concepts. 3rd ed. St. Louis: Mosby Elsevier; 2007.
  • 4. Carter MJ. Cost-effectiveness research in wound care: Definitions, approaches, and limitations. Ostomy Wound Manage. 2010;56:48-59.
  • 5. Choi GC, Lee HY, Lee SM. A survey of medical costs for health insurance patients in 2008. Seoul: National Health Insurance Corporation; 2009.
  • 6. Chung CH, Kim DJ, Kim JY, Kim HY, Kim HY, Min KY, et al. Current status of diabetic foot in Korean patients using national health insurance database. J Korean Diabetes Assoc. 2006;30:372-376. http://dx.doi.org/10.4093/jkda.2006.30.5.372
  • 7. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford university press; 2005.
  • 8. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Landsman AS, et al. Diabetic foot disorders: A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45:S1-S66. http://dx.doi.org/10.1016/S1067-2516(07)60001-5
  • 9. Harris C, Shannon R. An innovative enterostomal therapy nurse model of community wound care delivery. J Wound Ostomy Continence Nurs. 2008;35:169-183. http://dx.doi.org/10.1097/01.WON.0000313639.37247.c0
  • 10. Health Insurance Review & Assessment Service. Diseases of frequent home care visiting by year in national health insurance claim database. Home Care Nurses Association; 2010. Unpublished internal data.
  • 11. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20:169-181.
  • 12. Hwang NM. Cost-benefit analysis of the hospital-based home health care program for terminal cancer patients. Seoul, Korea: Seoul National University; 2000. Unpublished doctoral dissertation.
  • 13. Kang SW, Kwon YD, Ko SK, Ji NJ. Effects of home health care on social cost containment: Evidence from the patients undergone by knee arthroplasty in Korea. Korean J Health Econ Policy. 2005;11:85-99.
  • 14. Kim DI, Kim HC, Ko YJ, Sung IH, Shin BS, Oh WS, et al. Diabetic foot: Diagnosis & treatment. Seoul: Euihakmunhwa; 2006.
  • 15. Kim EY, Yang BM. Economic evaluation of long-term care service. Bogeongyeongjeyeongu. 2002;8:1-17.
  • 16. Kim JH. A cost-effectiveness analysis of long-term home oxygen therapy for patients with chronic obstruction pulmonary diseases (COPD) and policy implication in Korea. Korean J Health Econ Policy. 2005;11:1-38.
  • 17. Ku BJ, Choi DE, Joeng JO, Rha SY, Lee HJ, Hong WJ, et al. The clinical observation in diabetic patients with foot ulcer. Diabetes Monit. 2002;3:244-252.
  • 18. Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg. 1996;35:528-531. http://dx.doi.org/10.1016/S1067-2516(96)80125-6
  • 19. Lee TW. The costs of long-term care alternatives for the elderly. J Korean Acad Nurs Adm. 1998;4:351-361.
  • 20. Lee T. Methodological issues in nursing research on cost-effectiveness analysis. J Korean Acad Nurs. 2001;31:1202-1209.
  • 21. Lim JY. Cost-effectiveness analysis of home care service for cerebrovascular disease patients. Seoul: Korea University; 2001. Unpublished doctoral dissertation.
  • 22. Ministry of Health and Welfare. Guide on the medical institute base home health agency management. Seoul: Yimungieob; 2010.
  • 23. Nathwani D, Zambrowski JJ. Advisory group on home based and outpatient care (AdHOC): An international consensus statement on non-inpatient parental therapy. Clin Microbiol Infect. 2000;6:464-476. http://dx.doi.org/10.1046/j.1469-0691.2000.00113.x
  • 24. Park JY, Ko SK. Cost-benefit analysis of the community-based home health care program. Bogeongyeongjeyeongu. 2000;6:203-245.
  • 25. Paul IM, Phillips TA, Widome MD, Hollenbeak CS. Cost-effectiveness of postnatal home nursing visits for prevention of hospital care for jaundice and dehydration. Pediatrics. 2004;114:1015-1022. http://dx.doi.org/10.1542/peds.2003-0766-L
  • 26. Song CR, Han SH, Lee YA, Kim MY, Chae SM. An analysis of treatment types and home care services referral for patients with diabetic foot. J Korean Acad Soc Home Care Nurs. 2011;18:32-39.
  • 27. Stockl K, Tafesse E, Vanderplas A, Chang E. Cost of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004;27:2129-2134. http://dx.doi.org/10.2337/diacare.27.9.2129
  • 28. Sung YH, Hwang MS, Ru SS, Kim SJ. The effects of hospital based home care nursing on antibiotic treatment for patients with CMV infection following kidney transplant. Clin Nurs Res. 2005;10:129-144.
  • 29. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis. 2004;39:S132-S139. http://dx.doi.org/10.1086/383275
  • 30. Yang BM. Health economics. 2nd ed. Seoul: Nanam Press; 2009.
Figure 1
Scope of direct costs analysis for diabetic foot treatment.
jkana-19-437-g001.jpg
Table 1
Test of Homogeneity of Characteristics between Groups (N=60)
jkana-19-437-i001.jpg

HC=Home Care Services Group; Non-HC=Non-Home Care Services Group; ARB=Antibiotic-Resistant Bacteria; NPWT=Negative Pressure Wound Therapy; EGF=Epidermal Growth Factors; AC=Ambulatory Care.

*Missing data excluded; Texas university diabetic wound classification system; Multiple responses; §Fisher's exact test; Transforming data by natural log.

Table 2
Comparison of Direct Service Costs between Groups (Unit: Won, N=60)
jkana-19-437-i002.jpg

HC=Home Care Services Group; Non-HC=Non-Home Care Services Group.

*Missing data excluded; Transforming data by natural log.

Table 3
Comparison of Cost-effectiveness Ratio between Groups (N=60)
jkana-19-437-i003.jpg

HC=Home Care Services Group; Non-HC=Non-Home Care Services Group.

Table 4
Factors Affecting Direct Service Costs (N=60)
jkana-19-437-i004.jpg

*Transforming data by natural log.

Table 5
Sensitivity Analysis (N=60)
jkana-19-437-i005.jpg

Length=Length of Hospital Stay; Cost=Other Medical Costs; Duration=Duration to Cure; HC=Home Care Services Group; Non-HC=Non-Home Care Services Group; C=Cost; E=Effectiveness; C/E=Cost-effectiveness Ratio.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      Cost-effectiveness Analysis of Home Care Services for Patients with Diabetic Foot
      J Korean Acad Nurs Adm. 2013;19(4):437-448.   Published online September 30, 2013
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cost-effectiveness Analysis of Home Care Services for Patients with Diabetic Foot
      J Korean Acad Nurs Adm. 2013;19(4):437-448.   Published online September 30, 2013
      Close

      Figure

      • 0
      Cost-effectiveness Analysis of Home Care Services for Patients with Diabetic Foot
      Image
      Figure 1 Scope of direct costs analysis for diabetic foot treatment.
      Cost-effectiveness Analysis of Home Care Services for Patients with Diabetic Foot

      Test of Homogeneity of Characteristics between Groups (N=60)

      HC=Home Care Services Group; Non-HC=Non-Home Care Services Group; ARB=Antibiotic-Resistant Bacteria; NPWT=Negative Pressure Wound Therapy; EGF=Epidermal Growth Factors; AC=Ambulatory Care.

      *Missing data excluded; Texas university diabetic wound classification system; Multiple responses; §Fisher's exact test; Transforming data by natural log.

      Comparison of Direct Service Costs between Groups (Unit: Won, N=60)

      HC=Home Care Services Group; Non-HC=Non-Home Care Services Group.

      *Missing data excluded; Transforming data by natural log.

      Comparison of Cost-effectiveness Ratio between Groups (N=60)

      HC=Home Care Services Group; Non-HC=Non-Home Care Services Group.

      Factors Affecting Direct Service Costs (N=60)

      *Transforming data by natural log.

      Sensitivity Analysis (N=60)

      Length=Length of Hospital Stay; Cost=Other Medical Costs; Duration=Duration to Cure; HC=Home Care Services Group; Non-HC=Non-Home Care Services Group; C=Cost; E=Effectiveness; C/E=Cost-effectiveness Ratio.

      Table 1 Test of Homogeneity of Characteristics between Groups (N=60)

      HC=Home Care Services Group; Non-HC=Non-Home Care Services Group; ARB=Antibiotic-Resistant Bacteria; NPWT=Negative Pressure Wound Therapy; EGF=Epidermal Growth Factors; AC=Ambulatory Care.

      *Missing data excluded; Texas university diabetic wound classification system; Multiple responses; §Fisher's exact test; Transforming data by natural log.

      Table 2 Comparison of Direct Service Costs between Groups (Unit: Won, N=60)

      HC=Home Care Services Group; Non-HC=Non-Home Care Services Group.

      *Missing data excluded; Transforming data by natural log.

      Table 3 Comparison of Cost-effectiveness Ratio between Groups (N=60)

      HC=Home Care Services Group; Non-HC=Non-Home Care Services Group.

      Table 4 Factors Affecting Direct Service Costs (N=60)

      *Transforming data by natural log.

      Table 5 Sensitivity Analysis (N=60)

      Length=Length of Hospital Stay; Cost=Other Medical Costs; Duration=Duration to Cure; HC=Home Care Services Group; Non-HC=Non-Home Care Services Group; C=Cost; E=Effectiveness; C/E=Cost-effectiveness Ratio.

      TOP